<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19435" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chloramphenicol</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Oong</surname>
            <given-names>Ginny C.</given-names>
          </name>
          <aff>Newcastle University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tadi</surname>
            <given-names>Prasanna</given-names>
          </name>
          <aff>Asram Medical College, Eluru, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ginny Oong declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prasanna Tadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19435.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Chloramphenicol is a medication used in the management and treatment of superficial eye infections such as bacterial conjunctivitis, and otitis externa. It has also been used for the treatment of typhoid and cholera. Chloramphenicol is an antibiotic and is in the class of antimicrobials that inhibits protein synthesis. This activity outlines the indications, action, and contraindications for Chloramphenicol as a valuable agent in the treatment of superficial eye infections, otitis externa, Typhoid fever, and other severe life-threatening conditions, especially those caused by Haemophilus influenza. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the healthcare team in the management of patients with the infections stated above.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the mechanism of action and administration of chloramphenicol.</p></list-item><list-item><p>Describe the adverse effects and contraindications of chloramphenicol.</p></list-item><list-item><p>Review the appropriate monitoring and toxicity of chloramphenicol.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance the prescription and use of chloramphenicol and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19435&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19435">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19435.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Chloramphenicol is a synthetically manufactured broad-spectrum antibiotic. It was initially isolated from the bacteria <italic toggle="yes">Streptomyces venezuelae </italic>in 1948&#x000a0;and was the first bulk produced synthetic antibiotic.<xref ref-type="bibr" rid="article-19435.r1">[1]</xref>&#x000a0;However, chloramphenicol is a rarely used drug in the United States because of its known severe adverse effects, such as bone marrow toxicity and grey baby syndrome.</p>
        <p>Indications for its use include superficial eye infections (bacterial conjunctivitis), and otitis externa. It is also reserved for severe infections, such as rickettsial diseases, meningitis caused by <italic toggle="yes">Haemophilus Influenza, </italic><italic toggle="yes">Neisseria meningitidis, or Streptococcus pneumoniae, </italic>or in typhoid fever caused by <italic toggle="yes">Salmonella enterica serotype Typhi.<xref ref-type="bibr" rid="article-19435.r2">[2]</xref></italic><xref ref-type="bibr" rid="article-19435.r3">[3]</xref><xref ref-type="bibr" rid="article-19435.r4">[4]</xref><xref ref-type="bibr" rid="article-19435.r5">[5]</xref>&#x000a0;It can also be used for the treatment of cholera.<xref ref-type="bibr" rid="article-19435.r6">[6]</xref></p>
        <p>Chloramphenicol ointments are also used perioperatively as prophylaxis for surgical wound infections. This therapy is often necessary for plastic surgery and eye surgery.<xref ref-type="bibr" rid="article-19435.r7">[7]</xref><xref ref-type="bibr" rid="article-19435.r8">[8]</xref></p>
        <p>However, despite these indications, chloramphenicol should only be initiated if there is known susceptibility to the drug, and when other less dangerous antimicrobials are ineffective, not tolerated or contraindicated. Moreover, in vitro sensitivity tests have to be done to discontinue the medication as soon as other less dangerous antimicrobials demonstrate therapeutic effectiveness.</p>
      </sec>
      <sec id="article-19435.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>EFChloramphenicol is bacteriostatic but can be bactericidal in high concentrations. It is a broad-spectrum antibiotic be used against Gram-positive, Gram-negative, and anaerobic bacteria.<xref ref-type="bibr" rid="article-19435.r9">[9]</xref><xref ref-type="bibr" rid="article-19435.r10">[10]</xref>&#x000a0;Chloramphenicol works by inhibiting protein synthesis by binding to the 50S ribosomal subunit and directly preventing the formation of bacterial protein.<xref ref-type="bibr" rid="article-19435.r11">[11]</xref>&#x000a0;Other antibiotics that also target the 50S ribosomal subunit include clindamycin (a lincosamide) and macrolides such as erythromycin and clarithromycin. However, these drugs work differently. On a molecular level, chloramphenicol inhibits the attachment of transfer RNA to the A site on the 50S ribosome. In contrast, lincosamides act on the A and P sites, whereas macrolides block the tunnel through which nascent peptides exit.<xref ref-type="bibr" rid="article-19435.r12">[12]</xref></p>
      </sec>
      <sec id="article-19435.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Chloramphenicol can be administered topically as eye or ear drops, or as an eye ointment. It can also be given parenterally as intravenous injection or infusion or taken as oral capsules. Due to its high risk of adverse effects and toxicity, clinicians should prescribe chloramphenicol at therapeutic doses of not more than 50 mg/kg/day, given in divided doses at 6-hourly intervals. This dose may require an increase to 100 mg/kg/day for severe infections caused by moderately resistant organisms. If such increment in dosage is required, careful monitoring is imperative, with dose reductions back to 50mg/kg/day made as soon as possible. Also, dose reductions to 25 mg/kg/day may be necessary for neonates, and patients who have impaired liver or renal function.</p>
        <p>If administered as an intravenous infusion, it has to be given intermittently and diluted in either 0.9% sodium chloride or 5% glucose solutions.</p>
        <p>Clinicians should avoid using prolonged treatment with chloramphenicol.</p>
      </sec>
      <sec id="article-19435.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Chloramphenicol is associated with severe hematological side effects when administered systemically. Since 1982, chloramphenicol has reportedly caused fatal aplastic anemia, with possible increased risk when taken together with cimetidine. This adverse side effect can occur even with the topical administration of the drug, which is most likely due to the systemic absorption of the drug after topical application.<xref ref-type="bibr" rid="article-19435.r13">[13]</xref><xref ref-type="bibr" rid="article-19435.r14">[14]</xref></p>
        <p>There are two different types of chloramphenicol-induced blood dyscrasias. The first type is more common and is predictable, dose-related, and reversible. It causes mild anemia, with thrombocytopenia and neutropenia. The second form is an idiosyncratic reaction that has a later onset and is more likely to be fatal after pancytopenia develops. This type is unpredictable, irreversible, and dose-independent.<xref ref-type="bibr" rid="article-19435.r15">[15]</xref>&#x000a0;Aplastic anemia appears to occur as a result of chloramphenicol&#x02019;s effect on depleting ferritin concentrations in the mitochondria because of the shared ribosomal structures between bacteria and mitochondria, making the latter susceptible to the drug&#x02019;s ability to inhibit protein synthesis within the mitochondria.<xref ref-type="bibr" rid="article-19435.r15">[15]</xref>&#x000a0;There have also been cases of leukemia developing after aplastic anemia from chloramphenicol use.<xref ref-type="bibr" rid="article-19435.r16">[16]</xref></p>
        <p>Besides causing fatal aplastic anemia and bone marrow suppression, other side effects of chloramphenicol include ototoxicity&#x000a0;with the use of topical ear drops, gastrointestinal reactions such as oesophagitis with oral use, neurotoxicity, and severe metabolic acidosis.<xref ref-type="bibr" rid="article-19435.r17">[17]</xref><xref ref-type="bibr" rid="article-19435.r18">[18]</xref><xref ref-type="bibr" rid="article-19435.r19">[19]</xref><xref ref-type="bibr" rid="article-19435.r18">[18]</xref><xref ref-type="bibr" rid="article-19435.r17">[17]</xref><xref ref-type="bibr" rid="article-19435.r20">[20]</xref></p>
        <p>Optic neuritis is the most commonly associated neurotoxic complication that can arise from chloramphenicol use.<xref ref-type="bibr" rid="article-19435.r21">[21]</xref>&#x000a0;This adverse effect usually takes more than six weeks to manifest, presenting with either acute or subacute vision loss, with possible fundal changes. It may also present with peripheral neuropathy, which may present as numbness or tingling. If optic neuropathy occurs, the drug should be withdrawn immediately, which will usually lead to partial or complete recovery of vision.<xref ref-type="bibr" rid="article-19435.r22">[22]</xref></p>
      </sec>
      <sec id="article-19435.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Acute porphyria is an absolute contraindication to the use of chloramphenicol.<xref ref-type="bibr" rid="article-19435.r23">[23]</xref><xref ref-type="bibr" rid="article-19435.r24">[24]</xref>&#x000a0;Additionally, any known hypersensitivity to chloramphenicol, such as any previous anaphylactic reactions to the drug, should warrant the use of other antimicrobials. Signs of anaphylactic reaction to the medication include angioedema, bronchospasm, and urticaria.<xref ref-type="bibr" rid="article-19435.r25">[25]</xref>&#x000a0;Delayed onset hypersensitivity reactions such as contact dermatitis have also been reported. This reaction often presents 24&#x000a0;to 72 hours after the application of the medication with swelling and erythema.<xref ref-type="bibr" rid="article-19435.r26">[26]</xref></p>
        <p>Moreover, due to the potential risk of toxicity to neonates, chloramphenicol should also not be prescribed in neonates less than one week old, especially preterm infants. Currently, it is classed as a pregnancy category C drug and should be avoided in pregnancy or breastfeeding. However, there have been studies that show no associated teratogenicity with chloramphenicol use during the first trimester of pregnancy.<xref ref-type="bibr" rid="article-19435.r27">[27]</xref><xref ref-type="bibr" rid="article-19435.r28">[28]</xref><xref ref-type="bibr" rid="article-19435.r29">[29]</xref></p>
      </sec>
      <sec id="article-19435.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>With parenteral or oral administrations, plasma concentrations of the drug should be monitored, especially in the elderly, in children less than four years old, and those with hepatic impairment. The therapeutic range of chloramphenicol is often within 15 to 25 mg/L.<xref ref-type="bibr" rid="article-19435.r30">[30]</xref>&#x000a0;Moreover, baseline and routine blood should also take place while on the drug. These blood tests include a complete blood count, urea and electrolytes, renal function tests, and liver function tests. Female patients should have their pregnancy tests performed before starting the medication.</p>
        <p>Also, patients should be made aware of signs and symptoms associated with aplastic anemia, and be encouraged to report them should they occur during their treatment. These signs and symptoms include pallor, excessive tiredness, easy bruising, petechial rash, bleeding gums or epistaxis, and increased frequency of developing infections.</p>
      </sec>
      <sec id="article-19435.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>Chloramphenicol can be fatal in an overdose; this usually occurs with intravenous administration of the drug and is more likely to affect infants. Symptoms of poisoning include nausea and vomiting, abdominal distension, metabolic acidosis, hypotension, hypothermia, cardiovascular collapse, and coma.</p>
        <p>Grey baby syndrome is a well-known condition that arises from chloramphenicol toxicity in infants, especially affecting preterm neonates. It can also affect breastfed infants whose mothers are taking oral chloramphenicol.<xref ref-type="bibr" rid="article-19435.r31">[31]</xref>&#x000a0;A preterm neonate is more likely to be affected as their immature liver is unable to produce enough UDP-glucuronyltransferase enzyme needed to metabolize chloramphenicol, by glucuronidation, for renal excretion. The resultant accumulation of chloramphenicol in the infant will lead to gray baby syndrome. Symptoms of the grey baby syndrome vary depending on the serum concentration of the drug in the body. Examples of signs and symptoms of toxicity include poor feeding, irritability, abdominal distension, vomiting, grey skin discoloration, and sudden collapse from cardiovascular and respiratory complications.<xref ref-type="bibr" rid="article-19435.r32">[32]</xref><xref ref-type="bibr" rid="article-19435.r33">[33]</xref><xref ref-type="bibr" rid="article-19435.r34">[34]</xref>&#x000a0;Due to the possible risk of fatality associated with chloramphenicol exposure in neonates, an alternative drug should always be considered for breastfeeding mothers. However, if chloramphenicol is the therapeutic choice, close monitoring of the infant is required.</p>
      </sec>
      <sec id="article-19435.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>As with any medication, the prescription of chloramphenicol will require an interprofessional healthcare team to ensure safe prescribing of this antibiotic and maximum benefits attained by patients from its administration. This international healthcare team will consist of nurses, pharmacists, and physicians involved in the care of the patient. Prior to the initiation of the antibiotic, the physician should always get a thorough drug history from the patient to identify any potential allergy with chloramphenicol. Moreover, for female patients of child-bearing age, nurses can help with ensuring that they receive pregnancy testing, and a negative pregnancy status confirmed before patients start on the drug. The pharmacist can also work with the doctor to check that the patient receives the right dose, route, and frequency of the medication. Also, due to the risk of bone marrow suppression associated with chloramphenicol use, both the doctor and the pharmacist need to check for concomitant usage of other medications that also carries the risk of decreasing blood cell counts. Examples of drugs that can also cause bone marrow suppression include rifampicin, carbimazole, and trimethoprim. These medications should not be administered together with chloramphenicol.</p>
        <p>Nurses involved in the care of the patient can collaborate with physicians to ensure laboratory tests are performed regularly during the treatment for early detection of decreases in blood cell counts. Lastly, physicians, nurses, and pharmacists all share the responsibility of providing adequate patient education regarding the drug. Patients should understand the signs and symptoms suggestive of an adverse reaction to chloramphenicol that they can look out for and report. Proper patient education on the use of chloramphenicol can also help improve patients&#x02019; compliance and adherence to the medication.</p>
      </sec>
      <sec id="article-19435.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19435&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19435">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19435/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19435">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19435.s11">
        <title>References</title>
        <ref id="article-19435.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ehrlich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bartz</surname>
                <given-names>QR</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Joslyn</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Burkholder</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Chloromycetin, a New Antibiotic From a Soil Actinomycete.</article-title>
            <source>Science</source>
            <year>1947</year>
            <month>Oct</month>
            <day>31</day>
            <volume>106</volume>
            <issue>2757</issue>
            <fpage>417</fpage>
            <pub-id pub-id-type="pmid">17737966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paris</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Dumler</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>433</fpage>
            <page-range>433-9</page-range>
            <pub-id pub-id-type="pmid">27429138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirecka</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Etiological agents of bacterial meningitis in adults and antibiotic susceptibility of Streptococcus pneumoniae isolated between 2009-2016 from patients of Regional Specialist Hospital of Dr W&#x00142;. Biega&#x00144;ski in L&#x000f3;d&#x0017a;.</article-title>
            <source>Przegl Epidemiol</source>
            <year>2018</year>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>313</fpage>
            <page-range>313-324</page-range>
            <pub-id pub-id-type="pmid">30394054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sudarsanam</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Rupali</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tharyan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pre-admission antibiotics for suspected cases of meningococcal disease.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Jun</month>
            <day>14</day>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>CD005437</fpage>
            <pub-id pub-id-type="pmid">28613408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patil</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mule</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Sensitivity Pattern Of <italic>Salmonella typhi</italic> And Paratyphi A Isolates To Chloramphenicol And Other Anti-Typhoid Drugs: An In Vitro Study.</article-title>
            <source>Infect Drug Resist</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>3217</fpage>
            <page-range>3217-3225</page-range>
            <pub-id pub-id-type="pmid">31686872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>NAGAO</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Comparative study of roseomycin, streptomycin, chloramphenicol and homosulfanilamide on the effect of experimental cholera infections.</article-title>
            <source>Tohoku J Exp Med</source>
            <year>1953</year>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>191</fpage>
            <page-range>191-4</page-range>
            <pub-id pub-id-type="pmid">13136153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Platt</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Ramakrishnan</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Chloramphenicol use in plastic surgery.</article-title>
            <source>Br J Plast Surg</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>326</fpage>
            <page-range>326-7</page-range>
            <pub-id pub-id-type="pmid">10624313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Hunter-Smith</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rozen</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and adverse effects of topical chloramphenicol ointment use for surgical wounds: a systematic review.</article-title>
            <source>ANZ J Surg</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>88</volume>
            <issue>12</issue>
            <fpage>1243</fpage>
            <page-range>1243-1246</page-range>
            <pub-id pub-id-type="pmid">29573103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brook</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobials therapy of anaerobic infections.</article-title>
            <source>J Chemother</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>143</fpage>
            <page-range>143-50</page-range>
            <pub-id pub-id-type="pmid">26365224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dinos</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Athanassopoulos</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Missiri</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Giannopoulou</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Vlachogiannis</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Papadopoulos</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Papaioannou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kalpaxis</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Chloramphenicol Derivatives as Antibacterial and Anticancer Agents: Historic Problems and Current Solutions.</article-title>
            <source>Antibiotics (Basel)</source>
            <year>2016</year>
            <month>Jun</month>
            <day>03</day>
            <volume>5</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">27271676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <chapter-title>Chloramphenicol</chapter-title>
            <source>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]</source>
            <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2017</year>
            <month>1</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">31643435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schl&#x000fc;nzen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zarivach</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harms</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bashan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tocilj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Albrecht</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yonath</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria.</article-title>
            <source>Nature</source>
            <year>2001</year>
            <month>Oct</month>
            <day>25</day>
            <volume>413</volume>
            <issue>6858</issue>
            <fpage>814</fpage>
            <page-range>814-21</page-range>
            <pub-id pub-id-type="pmid">11677599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flach</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1982</year>
            <month>Sep</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>420</fpage>
            <page-range>420-2</page-range>
            <pub-id pub-id-type="pmid">7124889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>West</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>DeVault</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Clement</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine.</article-title>
            <source>Rev Infect Dis</source>
            <year>1988</year>
            <season>Sep-Oct</season>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>1048</fpage>
            <page-range>1048-51</page-range>
            <pub-id pub-id-type="pmid">3055188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnhill</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>4046</fpage>
            <page-range>4046-51</page-range>
            <pub-id pub-id-type="pmid">22615289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraumeni</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Bone marrow depression induced by chloramphenicol or phenylbutazone. Leukemia and other sequelae.</article-title>
            <source>JAMA</source>
            <year>1967</year>
            <month>Sep</month>
            <day>11</day>
            <volume>201</volume>
            <issue>11</issue>
            <fpage>828</fpage>
            <page-range>828-34</page-range>
            <pub-id pub-id-type="pmid">6071896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macfadyen</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Acuin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gamble</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2006</year>
            <month>Jan</month>
            <day>25</day>
            <issue>1</issue>
            <fpage>CD005608</fpage>
            <pub-id pub-id-type="pmid">16437533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andicochea</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Portouw</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Bokan</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Chloramphenicol and acute esophagitis in the emergency department.</article-title>
            <source>J Emerg Trauma Shock</source>
            <year>2015</year>
            <season>Jan-Mar</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-7</page-range>
            <pub-id pub-id-type="pmid">25709259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuroda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tateishi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Otsuki</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Neurotoxicity with chloramphenicol--an electron microscopic study.</article-title>
            <source>Folia Psychiatr Neurol Jpn</source>
            <year>1975</year>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-46</page-range>
            <pub-id pub-id-type="pmid">1158315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiest</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Cochran</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Tecklenburg</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Chloramphenicol toxicity revisited: a 12-year-old patient with a brain abscess.</article-title>
            <source>J Pediatr Pharmacol Ther</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-8</page-range>
            <pub-id pub-id-type="pmid">23118672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>Sh</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Acheson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Plant</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>An old friend revisited: chloramphenicol optic neuropathy.</article-title>
            <source>JRSM Short Rep</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>20</fpage>
            <pub-id pub-id-type="pmid">23560219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Godel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nemet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lazar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Chloramphenicol optic neuropathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1980</year>
            <month>Aug</month>
            <volume>98</volume>
            <issue>8</issue>
            <fpage>1417</fpage>
            <page-range>1417-21</page-range>
            <pub-id pub-id-type="pmid">7417077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thadani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Deacon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of porphyria.</article-title>
            <source>BMJ</source>
            <year>2000</year>
            <month>Jun</month>
            <day>17</day>
            <volume>320</volume>
            <issue>7250</issue>
            <fpage>1647</fpage>
            <page-range>1647-51</page-range>
            <pub-id pub-id-type="pmid">10856069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rath</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Padhy</surname>
                <given-names>UP</given-names>
              </name>
              <name>
                <surname>Marda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dash</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Intensive care management of patients with acute intermittent porphyria: Clinical report of four cases and review of literature.</article-title>
            <source>Indian J Crit Care Med</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>88</fpage>
            <page-range>88-91</page-range>
            <pub-id pub-id-type="pmid">20859493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liphshitz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Loewenstein</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Anaphylactic reaction following application of chloramphenicol eye ointment.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1991</year>
            <month>Jan</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <pub-id pub-id-type="pmid">1991092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livingston</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Butterworth</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Belt</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Reaction or infection: topical chloramphenicol treatment.</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>e20</fpage>
            <page-range>e20-1</page-range>
            <pub-id pub-id-type="pmid">23317719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomseth</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cejvanovic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Jimenez-Solem</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Poulsen</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Exposure to topical chloramphenicol during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>7</issue>
            <fpage>651</fpage>
            <page-range>651-3</page-range>
            <pub-id pub-id-type="pmid">25923453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czeizel</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Rockenbauer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>S&#x000f8;rensen</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A population-based case-control teratologic study of oral chloramphenicol treatment during pregnancy.</article-title>
            <source>Eur J Epidemiol</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>323</fpage>
            <page-range>323-7</page-range>
            <pub-id pub-id-type="pmid">10959939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Kwok</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Use of ophthalmic medications during pregnancy.</article-title>
            <source>Hong Kong Med J</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>191</fpage>
            <page-range>191-5</page-range>
            <pub-id pub-id-type="pmid">15181224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vozeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Follath</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Serum level monitoring of antibacterial drugs. A review.</article-title>
            <source>Clin Pharmacokinet</source>
            <year>1984</year>
            <season>Nov-Dec</season>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>475</fpage>
            <page-range>475-92</page-range>
            <pub-id pub-id-type="pmid">6391780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r31">
          <label>31</label>
          <element-citation publication-type="book">
            <chapter-title>Chloramphenicol</chapter-title>
            <source>Drugs and Lactation Database (LactMed&#x000ae;) [Internet]</source>
            <publisher-name>National Institute of Child Health and Human Development</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2021</year>
            <month>3</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30000554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SUTHERLAND</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol.</article-title>
            <source>AMA J Dis Child</source>
            <year>1959</year>
            <month>Jun</month>
            <volume>97</volume>
            <issue>6</issue>
            <fpage>761</fpage>
            <page-range>761-7</page-range>
            <pub-id pub-id-type="pmid">13649107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulhall</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Louvois</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hurley</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Chloramphenicol toxicity in neonates: its incidence and prevention.</article-title>
            <source>Br Med J (Clin Res Ed)</source>
            <year>1983</year>
            <month>Nov</month>
            <day>12</day>
            <volume>287</volume>
            <issue>6403</issue>
            <fpage>1424</fpage>
            <page-range>1424-7</page-range>
            <pub-id pub-id-type="pmid">6416440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19435.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Craft</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Brocklebank</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Hey</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>The 'grey toddler'. Chloramphenicol toxicity.</article-title>
            <source>Arch Dis Child</source>
            <year>1974</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>235</fpage>
            <page-range>235-7</page-range>
            <pub-id pub-id-type="pmid">4825630</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
